Oscar Health (NYSE:OSCR – Get Free Report) and bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.
Profitability
This table compares Oscar Health and bioAffinity Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Oscar Health | 4.90% | 49.39% | 9.29% |
| bioAffinity Technologies | -278.90% | -293.44% | -160.36% |
Risk and Volatility
Oscar Health has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500.
Institutional & Insider Ownership
75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by insiders. Comparatively, 2.4% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Oscar Health and bioAffinity Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Oscar Health | 1 | 7 | 4 | 1 | 2.38 |
| bioAffinity Technologies | 1 | 0 | 0 | 0 | 1.00 |
Oscar Health presently has a consensus target price of $34.60, indicating a potential upside of 7.75%. Given Oscar Health’s stronger consensus rating and higher possible upside, analysts plainly believe Oscar Health is more favorable than bioAffinity Technologies.
Valuation and Earnings
This table compares Oscar Health and bioAffinity Technologies”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Oscar Health | $17.47 billion | 0.57 | -$443.15 million | $2.42 | 13.27 |
| bioAffinity Technologies | $6.16 million | 0.24 | -$14.91 million | ($44.27) | -0.05 |
bioAffinity Technologies has lower revenue, but higher earnings than Oscar Health. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.
Summary
Oscar Health beats bioAffinity Technologies on 13 of the 14 factors compared between the two stocks.
About Oscar Health
Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar’s products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.
About bioAffinity Technologies
bioAffinity Technologies, Inc. is a biotechnology company focused on developing diagnostic and therapeutic products for cancer and other serious diseases. The company’s platform uses porphyrin-based compounds designed to selectively identify or target abnormal cells, with the goal of supporting earlier disease detection and more precise treatment. Its lead diagnostic product, CyPath Lung, is an investigational, noninvasive urine test intended to aid in the detection of lung cancer. The test uses an inhaled porphyrin compound that can bind to cancer cells in the lungs; the resulting material is collected in urine and analyzed using laboratory methods.
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
